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■ Abstract The phosphorylation status of myofibrillar proteins influences
the Ca2+responsiveness of the myofilaments,but the contribution of and the
interaction between the individual components is poorly characterized.
Therefore,in Langendorff perfused rat hearts (n=30),the phosphorylation
levels of cardiac myosin binding protein-C (cMyBP-C), troponin I and T
(cTnI, cTnT) and myosin light chain 1 and 2 (MLC-1, MLC-2) were deter-
mined by 1- and 2-dimensional gel electrophoresis. Isometric force devel-
opment,its Ca2+-sensitivity,the rate of tension redevelopment (ktr) and pas-
sive force (Fpas) were studied at optimal sarcomere length (2.2μm) in
mechanically isolated,permeabilized cardiomyocytes at 15 °C.Protein phos-
phorylation was varied by:1) blocking spontaneous cardiac activity by lido-
caine (0.35 mM; Quiescence); 2) electrical stimulation of the hearts at 5 Hz
(Contraction) and 3. treatment of contracting hearts with Isoprenaline
(1μM).MLC-2 phosphorylation was increased in the Contraction group al-
most 2-fold, relative to the Quiescence group, whereas cMyBP-C and cTnI
phosphorylation remained the same. Isoprenaline resulted in 3.7-fold in-
creases in both cMyBP-C and cTnI phosphorylation,but did not result in a
further increase in MLC-2 phosphorylation.No significant differences were
found in maximum force and ktrbetween groups,both before and after pro-
tein kinase A (PKA) treatment.Ca2+-sensitivity in the Contraction and Iso-
prenaline groups was significantly reduced in comparison to the Quiescence
group. These differences were largely abolished by PKA and Fpas was re-
duced. These results highlight the impact of PKA-dependent phosphoryla-
tion on Ca2+-sensitivity and provide evidence for an interaction between the
effects of TnI and MLC-2 phosphorylation.
■ Key words contractile function – Ca2+-sensitivity – cardiac – myocyte –
phosphorylation
Effects of contractile protein
phosphorylation on force development 
in permeabilized rat cardiac myocytes
Introduction
The activity of the contractile apparatus in cardiac
myocytes is determined by the intracellular Ca2+ con-
centration and the sensitivity of the myofilaments to
Ca2+.The Ca 2+-sensitivity of the myofilaments is modu-
lated by the delicate balance between phosphorylation
by kinases,e.g.protein kinase A and C (PKA and PKC),
myosin light chain kinase (MLCK) and the Ca2+calmod-
ulin dependent kinase II (CaMK II), and dephosphory-
lation by phosphatases, e.g. protein phosphatase 1 and
2A (PP-1 and PP-2A).For recent overviews see [2,8,22].
In the last decades, the impact of phosphorylation on
Ca2+-sensitivity of only a limited number of contractile
proteins has been resolved,whereas the interactions be-
tween the various proteins are largely unclear.
One of the proteins whose role is not completely un-S. C. Verduijn et al. 477
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derstood is myosin binding protein C (CMyBP-C).This
approximately 150 kDa protein,discovered more than 30
years ago,is part of the thick (myosin) filament [30] and
shows up as the third (=C) band in an SDS gel from
crude myosin [35].The interest in the functional role of
cMyBP-C has risen with the discovery of frequently oc-
curring mutations in the MYBPC3 gene that result in the
phenotype of hypertrophic cardiomyopathy [e.g.29].It
has been found that the C terminal part of cMyBP-C
binds to titin and to the light meromyosin region of
myosin [9,21],while the N terminus binds to the myosin
S2 region [13, 20]. The N terminal region of rat cardiac
cMyBP-C contains three serine phosphorylation sites
(S279,S288,S308),phosphorylatable with different stoi-
chiometry by PKA and PKC [26]. Recently, results have
been presented indicating the existence of additional
phosphorylation sites [45]. Several lines of evidence
suggest that phosphorylation of S288 by CaMK II is re-
quired before S279 and S308 can be phosphorylated by
PKA [12,24,33].On the other hand,cMyBP-C can be de-
phosphorylated in vitro both by PP-1 and PP-2A [34].As
a consequence of the presence of these multiple phos-
phorylation sites and the complex signal transduction
routes involved,the functional effects of cMyBP-C phos-
phorylation are largely unclear.
It has been proposed that cMyBP-C phosphorylation
modulates the interaction between cMyBP-C and the S2
region of myosin [13,20] resulting in an increase in the
proximity of myosin to actin. This would enhance the
probability of crossbridge formation [15, 37, 43]. Ac-
cordingly, the PKA-mediated phosphorylation of
cMyBP-C might contribute to the increased cardiac out-
put in response to β-adrenergic stimulation [37].
The phosphorylation of myosin light chain 2 (MLC-
2),cardiac troponin T (cTnT) and troponin I (cTnI) has
considerable impact on contractile function as such,but
could also modulate the effects of cMyBP-C phosphory-
lation and vice versa. For instance, recently it has been
suggested from a study using cMyBP-C knockout mice
that myofilament desensitisation induced by PKA re-
quires the presence of cMyBP-C [4].MLC-2 phosphory-
lation by the Ca2+-calmodulin-dependent MLCK results
in an increase in Ca2+-sensitivity [39].In human tissue,
our laboratory has presented evidence that the effects of
MLC-2 dephosphorylation depend on the level of cTnI
phosphorylation, i.e. an interaction between the effect
of the phosphorylation of a thin (actin) filament protein
and that of a thick (myosin) filament protein [42].
Therefore, in the present study we induced differ-
ences in the degree of phosphorylation of the myofila-
ments to explore the role of phosphorylation of cMyBP-
C in isolated rat ventricular myocytes under
physiological conditions, taken into account the phos-
phorylation levels of the other contractile proteins such
as MLC-2,cTnT and cTnI.
Methods
A thoracotomy was performed on Wistar rats (300±7 g)
anaesthetised with ketamine 0.2ml/kg i.m. and pento-
barbital 60mg/kg i.p.The heart was quickly excised and
placed in ice cold Tyrode solution (in mM: NaCl: 120,
KCl:5,MgCl2:1.2,NaH2PO4:2,NaHCO 3:27,d-glucose:10
saturated with 95% O2and 5% CO2) supplemented with
30 mM 2,3-butanedione monoxime (BDM).The “Princi-
ples of laboratory animal care” (NIH publication No
86–23, revised 1985) were followed and all protocols
were approved by the Animal Experimental Welfare
Committee of the VU University Medical Center. The
CaCl2 concentrations in the Tyrode solution were either
0.2 mM, 1.36 mM or 2.5 mM, as specified in each sub-
protocol. The aorta was cannulated and the complete
heart was mounted on a Langendorff apparatus in
which coronary perfusion was maintained at 15ml/min
using 95% O2–5% CO2 equilibrated Tyrode solution
without BDM at 37 °C (pH 7.4).The atria were removed
and the ventricles could be stimulated electrically via
two platinum electrodes.
We aimed at different cMyBP-C phosphorylation lev-
els and used different experimental conditions as tools
to achieve this.Phosphorylation of cMyBP-C will be low
in quiescent hearts perfused with lidocaine at a rela-
tively low Ca2+ concentration [32].In theory,higher lev-
els of phosphorylation can be obtained by β-adrenergic
stimulation,enhancement of the CaMK II activity by an
increase in the time averaged intracellular Ca2+ concen-
tration,and/or by blockade of phosphatase activity [11,
28]. These considerations led to the following experi-
mental groups.Hearts (n=30) were perfused according
to Langendorff for 90 min at 37 °C with Q1:0.2 mM Ca2+
and 0.35 mM lidocaine (Lido) to attain quiescence
(n=4),Q2: physiological Ca2+ (1.36 mM)+Lido (n=5),
C1: 1.36 mM Ca2+, stimulation at 5 Hz (n=8), C2: 5 Hz
stimulation at a high Ca2+ (2.5 mM)+okadaic acid (OA:
0.1 μM) (n=5),Iso1:1.36 mM Ca2+,5 Hz stimulation fol-
lowed by 2 min of Isoprenaline (1 μM) (n=4) and Iso2:
1.36 mM Ca2+,5 Hz stimulation+OA followed by 2 min
of Isoprenaline+OA (n=4).
Immediately after interruption of the Langendorff
perfusion the heart was flash frozen in liquid nitrogen.
The left ventricle (LV) plus septum were separated from
the rest of the heart and stored at –80 °C until further
analysis.
■ Myocyte measurements
A small piece (~25mg) ofLV tissue was defrosted in cold
relaxing solution, containing in mM free Mg2+:1 ,K C l :
100,EGTA:2,Mg-ATP:4,imidazole:10 (pH 7.0,adjusted
with KOH). This piece was cut into small pieces with
scissors and homogenized in 5–10 s, using a tissue ho-478 Basic Research in Cardiology, Vol. ■, No. ■(200■)
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mogenizer.The resultant suspension of small clumps of
myocytes, single myocyte-sized preparations and cell
fragments was treated with 0.3% Triton X-100 in relax-
ing solution (5 min), in order to permeabilize the car-
diomyocytes. The suspension was washed two times in
relaxing solution without Triton and kept at 0 °C for 6–8
h [41].
A single myocyte was attached with silicon adhesive
to thin stainless steel needles while viewed by an in-
verted microscope. One needle was attached to a force
transducer (SensoNor,Horten,Norway) and the other to
a piezoelectric motor (Physike Instrumente, Wald-
brunn,Germany),both connected to joystick-controlled
micromanipulators. During cell attachment and subse-
quent force measurements myocytes were viewed at
320X magnification.Images were captured by means of
a CCD camera and stored on a personal computer. See
Fig.1 for a typical example. Average sarcomere length
was determined by means of a spatial Fourier transform
as described previously and adjusted to approximately
2.2μm [6].The diameters of the preparation were mea-
sured microscopically, in two almost perpendicular di-
rections. Cross-sectional area was calculated assuming
an elliptical cross-section.
After curing of the glue for 50 min, the preparation
was transferred from the mounting area to a small tem-
perature controlled well (15 °C; volume 79μl), contain-
ing relaxing solution,from which the myocyte could be
transferred to a similar temperature controlled well con-
taining activating solution. Relaxing and activating so-
lutions for force measurements contained, respectively
(in mM): MgCl2: 6.48 and 6.28, Na2ATP: 5.89 and 5.97,
EGTA: 7.0 and 0, CaEGTA: 0 and 7.0. In addition, both
contained 14.5 mM phosphocreatine and 60 mM BES
(pH:7.1, adjusted with KOH). The ionic strength of the
solutions was adjusted to 180 mM with K-propionate.
The pCa,i.e.-log10 [Ca2+],of the relaxing and activating
solution was, respectively, 9 and 4.5. Calculated free
Mg2+ and MgATP concentrations were 1 and 5 mM, re-
spectively.Solutions with lower free Ca2+concentrations
were obtained by appropriate mixing of the activating
and relaxing solutions, assuming an apparent stability
constant of the Ca-EGTA complex of 106.56.
Isometric force was measured after the preparation
was transferred from relaxing to activating solution,by
moving the stage of the inverted microscope. When
steady force was reached, the myocyte was reduced in
length by 20% within 2ms using the piezoelectric mo-
tor and restretched after 30ms (slack test).As a result of
this intervention, force first dropped to zero and then
quickly redeveloped to the original steady-state level.A
single exponential was fitted to force redevelopment to
estimate the rate constant of force redevelopment (ktr).
Subsequently,the myocyte was returned to the relaxing
solution,and a second slack test (10 s duration) was per-
formed allowing the determination of passive force
(Fpas). Active isometric force was calculated from the
force level in activating solution – Fpas.Force and length
signals were monitored using a pen-recorder and stored
on a personal computer. Sampling rate during the ex-
periment was 20 Hz,and 500 or 1000 Hz during the first
slack-test.
Ca2+-sensitivity (pCa50) was determined using differ-
ent pCa values (5.0,5.2,5.4,5.6,5.8 and 6.0) in a random
order, bracketed by control activations at pCa 4.5. The
initial control force at pCa 4.5 was used to calculate the
maximal force per cross-sectional area.The force values
at submaximal [Ca2+] were normalized to the interpo-
lated control values.Thereafter,the myocytes were incu-
bated for 40 min at 20 °C in relaxing solution containing
6 mM dithiothreitol (DTT) (time control) or 6 mM DTT
and 100 U/ml of the catalytic subunit of PKA (Sigma,
P2645 from bovine heart) and the Ca2+-sensitivity mea-
surements were repeated. Experimental series where
maximum force value during the control activations at
pCa 4.5 declined more than 20%, were not used for
analysis.
■ Time dependent phosphorylation in vitro
Homogenized tissue samples (400μg dry weight) were
incubated in 0.1ml of relaxing solution with PKA (Cal-
biochem,Cat.No.539481,1250 U/ml),protease inhibitor
cocktail 10μl/ml (Sigma,P8340),phosphatase inhibitor
cocktail 1 and 2 (10μl/ml each,Sigma,P2850 and P3750,
respectively) and 2.5μl/ml 10% Triton for 0,5,10,15,20,
30 and 60 min at 30 °C.The reaction was stopped by ad-
dition of cold (–20 °C) trichloroacetic acid dissolved in
acetone (TCA; 10% v/v). Phosphorylation was deter-
mined from ProQ diamond stained 1D gradient gels (see
below).
Fig. 1 Single cardiomyocyte, isolated from left ventricular tissue from the Quies-
cence group, glued between force transducer and piezoelectric motorResults
The experimental conditions during Langendorffperfu-
sion were varied in order to attain different levels of
contractile protein phosphorylation as described in
Methods.As can be seen from the overviews of the re-
sults in Tables 1 and 2, there were no significant differ-
ences in the averaged data of the Quiescence (Q1, Q2),
Contraction (C1, C2) and Isoprenaline subgroups (Iso,
Iso+OA). Therefore, for the ease of presentation in the
figures and discussion,the data within each of the three
main groups were pooled,but the data of the subgroups
are given in Tables 1 and 2.
■ Force measurements
An example of the force recording in a single permeabi-
lized cardiomyocyte is shown in Fig.2. From each ani-
mal 2–4 myocytes were analysed in order to calculate the
mean force parameter values per animal.Subsequently,
the means ofthe values ofall animals in each (sub)group
were calculated to allow a comparison with the contrac-
tile protein phosphorylation status of the tissue. The
maximal active force per cross-sectional area (Fmax) was
measured at saturating Ca2+-concentration (pCa 4.5)
and 2.2μm sarcomere length.No significant differences
were found between the groups (Fig.2B; Table1). The
overall averaged value amounted to 16.5±1.1 kN/m2.
Passive force (Fpas) also did not differ between groups.
The overall averaged value amounted to 2.7±0.3 kN/m2,
i.e.15±2% of the total (Ftot=F max+F pas) force.The rate
of force redevelopment (ktr) at saturating Ca2+-concen-
tration did not differ between groups (Fig.2C; Table1).
The relation obtained between active force (Fact) and
the free Ca2+-concentration is shown in Fig.3. For each
cardiomyocyte the data were fitted to the modified Hill
equation and for each animal the mean parameter val-
ues of Fmax,p C a 50 and nH were obtained and group
means were calculated (Fig.3D; Table1).These data in-
dicate that Ca2+-sensitivity (pCa50) in the Quiescence
group was significantly higher than in the Contraction
and Isoprenaline groups (P<0.05).The steepness of the
Ca2+-sensitivity relations (nH) did not differ between
groups (Table1). The rate of force redevelopment (ktr)
decreased significantly when the pCa in the activating
solutions was increased from 4.5 to 5.4 with 19.4±2.4%.
However, its Ca2+-dependence did not differ between
groups.
The impact of saturating PKA-sensitive phosphory-
lation of cMyBP-C,cTnI and (possibly) titin on force de-
velopment was studied by repeating the Ca2+-sensitivity
measurements after incubation of the cardiomyocytes
with the active subunit of PKA.The effect of PKA treat-
ment on the Ca2+-sensitivity of Fact is illustrated in
Fig.3A,B and C for the Quiescence,Contraction and Iso-
S. C. Verduijn et al. 479
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■ Two-dimensional gel electrophoresis
Part of the LV was treated with TCA to maintain the
phosphorylation status of the contractile proteins.
Freeze dried samples were homogenized in 1D sample
buffer (62.5 mM TRIS (pH 6.8), 15% glycerol, 1% SDS
and 1.5% hydroxyethyldisulfide), and diluted [1:17] in
2D sample buffer (7 M urea,2.5 M thiourea,4% CHAPS,
0.5% ampholytes pH 4–7, 10% glycerol and 10% iso-
propanol).2D-gel electrophoresis of the samples (200μg
dry weight) was performed using immobiline strips
with a pH gradient of 4–7 as described previously [42]
to determine MLC-1,MLC-2 and cTnT phosphorylation
from the Coomassie stained gels.
■ ProQ diamond staining
TCA-treated tissue was washed 3 times in acetone and
dissolved in 1D sample buffer with 100 mM DTT,heated
(5 min at 80 °C), centrifuged (20 min, 12000 g at 20 °C)
and a sample (~35μg dry weight in 25μl) was applied on
a 4–15% gradient gel (Criterion, BioRad). The gel was
run at 100 V for 30 min followed by 200 V for 50 min.The
gel was stained for one hour with ProQ Diamond (Mol-
ecular Probes,Eugene OR,USA) according to the man-
ufacturer’s instructions. Staining was analysed with a
LAS-3000 system (Fuji Science Imaging Systems) and
AIDA Image analyser software (Isotopenmeßgeräte
GmbH, Staubenhardt, Germany). Subsequently, the gel
was washed and stained with Sypro Ruby (Molecular
Probes) according to the manufacturer’s instructions,
and analysed.
■ Data analysis
The force–pCa relation was fitted using a modified Hill
equation
F(Ca2+)/Fmax=[Ca 2+]nH/(Ca50
nH+[Ca 2+]nH)
where F is steady state force.Fmaxdenotes the steady iso-
metric force at saturating Ca2+ concentration, the Hill
coefficient nH is a measure of the steepness of the rela-
tionship,and Ca50(or pCa50) represents the mid-point of
the relation.Values are given as means ± S.E.M.of n ex-
periments. Differences between the groups were tested
by means of an ANOVA followed by Bonferroni, differ-
ences due to PKA treatment were analysed in the main
groups using a paired Student’s t-test.A P-value of<0.05
was considered significant.480 Basic Research in Cardiology, Vol. ■, No. ■(200■)
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Fig. 2 A Contraction-relaxation sequence recorded from a cardiomyocyte from
the Quiescence group at maximally activating Ca2+concentration (pCa 4.5). *Slack
test used to determine the rate of force redevelopment (ktr). Factrepresents the ac-
tive force development in Ca2+-containing activating solution. Fpas represents the
passive force development measured in relaxing solution (pCa 9). BAveraged val-
ues (±SEM) of the active force development at maximally activating Ca2+-concen-
tration normalized for cross-sectional area (Fmax) in the Quiescence (Q), Contraction
(C) and Isoprenaline (Iso) group. CAveraged values (±SEM) of ktrat maximally ac-
tivating Ca2+concentration in the Quiescence, Contraction and Isoprenaline group.
Both Fmaxand ktrdid not vary significantly between groups (ANOVA)
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Aprenaline group,respectively.PKA caused a decrease in
Ca2+-sensitivity, which was larger in the Quiescence
group than in the Contraction and Isoprenaline group.
After PKA, the pCa50 values in the three groups were
comparable (Fig.3D). PKA incubation resulted in a
small but significant reduction in Fpas in the Quiescence
and in the Contraction group but did not alter Fmax
(Table1).Control incubations without PKA did not have
any effect on the force parameters or their Ca2+-sensi-
tivity (data not shown).
To assess the effect ofPKA on ktr,the ktr– pCa and the
ktr – Fact relations were studied before and after PKA
treatment.Accurate determination of ktrwas only possi-
ble at relatively high forces,i.e.in the pCa range between
4.5 and 5.4.In general,it appeared that ktrat submaximal
pCa values before PKA treatment was somewhat less
than the corresponding values before PKA treatment.
■ Protein analysis
The endogenous phosphorylation levels of contractile
proteins in TCA-treated tissue from the flash frozen
hearts were determined from 2D-gels (cTnT,MLC-1 and
MLC-2) and from ProQ Diamond stained 1D-gels
(cMyBP-C,cTnT,cTnI and MLC-2).Typical examples of
the gels obtained are shown in Figs.4 and 5.The 2D-gels
(pH range 4–7) allow the distinction between different
phosphorylated forms of cTnT, MLC-1 and MLC-2 and
permit the quantification of the relative distribution of
these forms of each protein.The ProQ Diamond stained
1D-gels are convenient to determine the overall degree
of phosphorylation of high molecular weight proteins
such as cMyBP-C,and very basic proteins such as cTnI.
There was good agreement in the results of protein
phosphorylation in the samples of the various groups,
where comparisons could be made (cTnT and MLC-2).
In both cases cTnT phosphorylation,expressed as a per-
centage for 2D-gels or normalized for cMyBP-C protein
content in each sample derived from Sypro Ruby stained
1D-gels, did not vary between groups. Therefore nor-
malization of the phosphostaining of other protein
bands on the ProQ Diamond gels could be performed
relative to the staining intensity of the corresponding
cTnT band in each lane.
2D-analysis by means of Sypro Ruby and ProQ Dia-
mond staining and Western Immunoblotting using a
monoclonal cTnT antibody (2G3, RDI Research Diag-
nostics) clearly indicated that the group labeled as cTnT
in Fig.4 consists of a predominant lower molecular
weight form, which is mainly mono-phosphorylated
and slightly bis-phosphorylated. In addition, a less
prominent group with a slightly higher molecular
weight at a slightly more acidic pH can be seen,included
in the cTnT box, which possesses a very similar phos-
phorylation pattern. In addition, the ProQ Diamond
stained gel confirmed the identity and distribution of
the MLC-2 phospho-species. These images also pro-
vided evidence for the presence of a bis-phosphorylated
form of MLC-2 with very low abundance.The intensity
of this spot was negligible relative to the intensity of the
mono-phosphorylated spot.
Fig. 3 A, B, C Isometric force normal-
ized to the force at saturating Ca2+ con-
centration plotted as a function of the
pCa of the activating solution, before
and after PKA (100 U/ml) incubation for
40 min at 20 °C, in the Quiescence, Con-
traction and Isoprenaline group, respec-
tively. DBar graph illustrating the differ-
ences in Ca2+-sensitivity (pCa50) in the
three groups. At baseline pCa50was sig-
nificantly lower in the Contraction and
Isoprenaline groups than in the Quies-
cence group (* P < 0.05 vs Quiescence
group; Bonferroni post hoc test). After
PKA treatment Ca2+-sensitivity de-
creased, and the pCa50 values attained
were fairly similar before
before
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From the results presented in Table2, a comparison
can be made with regards to the MLC-2 phosphorylation
between the results obtained using ProQ diamond stain-
ing of 1D gels and the Coomassie stained 2D-gels.It can
be noted that the correspondence between the results of
the two different techniques is good and that the out-
come of the statistical analysis of the differences in
MLC-2 phosphorylation between experimental groups
does not depend on the quantitation method used.
An overview of differences in phosphorylation of
cMyBP-C,cTnI and MLC-2 in the Quiescence,Contrac-
tion and Isoprenaline group is shown in Fig.6A, B and
C,respectively.A complete summary of the data is given
in Table2. Significant differences were found in the
phosphorylation of cMyBP-C, cTnI, MLC-1 and MLC-2
in the three groups (ANOVA),while cTnT phosphoryla-
tion (approximately 80% of total cTnT) remained the
same. Cardiac MyBP-C and cTnI phosphorylation were
markedly increased (3.7-fold) in the Isoprenaline group
relative to the Quiescence group (P<0.01).The average
cMyBP-C phosphorylation in the Contraction group was
somewhat elevated (1.4-fold) but the difference between
the Quiescence and Contraction group was not signifi-
cant (Bonferroni post-hoc test).MLC-2 phosphorylation
increased significantly from 22.4% in the Quiescence
Fig. 4 Coomassie blue stained 2D-gel of left ventric-
ular tissue (200 μg dry weight) of the Quiescence
group. On the horizontal axis proteins are separated
by isoelectric point (pH range: 4–7) and vertically
proteins are separated based on molecular weight
(top: ~200 kDa, bottom: 15 kDa). Abbreviations used:
troponin T (cTnT), myosin light chain 1 (MLC-1),
myosin light chain 2 (MLC-2). The relative expression
of the unphosphorylated (U), mono (P) and bis (2P)
phosphorylated forms of a number of proteins can be
quantitated from these 2D-gels. The lower panels il-
lustrate the MLC-2 and cTnT regions in 2D-gels from
the Quiescence (Q), Contraction (C) and Isoprenaline
(Iso) group (approximately 200 μg dry weight of sam-
ple). MLC-2 was more phosphorylated in the Contrac-
tion and Isoprenaline group in comparison to the Qui-
escence group. The degree of cTnT phosphorylation
was very similar as can be seen from the correspon-
dence in the relative distribution of the intensities in
the U, P and 2P spots
Actin 
cTnT 
MLC-1 
MLC-2 
pH 4  pH 7 
MLC-2 cTnT 
PP  U 2P
Q 
C 
Iso 
U
Fig. 5 A Representative 4–15 % gradient gel stained with Pro-Q Diamond from
samples (approximately 35 μg dry weight) of the Quiescence (Q), Contraction (C)
and Isoprenaline (Iso) group. BThe same gel was subsequently stained with Sypro
Ruby to visualize all proteins. M molecular weight PeppermintStick Phosphopro-
tein marker in which ovalbumin (45 kDa) and β-casein (23 kDa) are phosphory-
lated. MHC myosin heavy chain. The degree of phosphorylation of myosin binding
protein C (cMyBP-C), troponin I (cTnI) and myosin light chain 2 (MLC-2) was higher
in the Isoprenaline group than in the Quiescence and Contraction group, while the
phosphorylation status of troponin T (cTnT) did not vary between groups
Q
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23 
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C M Q C Iso M
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ABgroup to 36.7% in the Contraction group and to 42% in
the Isoprenaline group.MLC-2 phosphorylation did not
differ significantly between the Contraction group and
Isoprenaline group, indicating that 2 min of 1μM Iso-
prenaline did not change MLC-2 phosphorylation.
MLC-1 was mainly in the dephosphorylated form; the
MLC-1 phosphorylation was increased slightly
(P<0.05) from 13.5% in the Quiescence group to 19%
in the Isoprenaline group (Table2).Although the effect
of okadaic acid was not significant,this increase might –
at least partly – be caused by okadaic acid,which blocks
PP-1 and PP-2 activity.
Fig. 6 A, B Quantitative analysis of cMyBP-C and
cTnI phosphorylation from 1D-gels by Pro-Q Dia-
mond and Sypro Ruby staining. Pro-Q Diamond in-
tensity signals of cMyBP-C and cTnI were normalized
to cTnT staining intensity in the same lane. Averaged
values (± SEM) values are shown in the Quiescence
(Q), Contraction (C) and Isoprenaline (Iso) group.
cMyBP-C and cTnI phosphorylation in the Isopre-
naline group were significantly increased relative to
the Quiescence and Contraction group. C MLC-2
phosphorylation obtained by 2D-gel electrophoresis
expressed as percentage of mono-phosphorylated
MLC-2 relative to total MLC-2 intensity. MLC-2 phos-
phorylation in the Contraction and Isoprenaline
groups was significantly increased relative to the Qui-
escence group. D, EEffect of incubation of tissue from
the Quiescence group with the active subunit of pro-
tein kinase A. cMyBP-C and cTnI phosphorylation in-
creased with the duration of the incubation and sat-
urated after approximately 30 min. The final levels
attained are smaller than the corresponding levels
reached in the Isoprenaline group, indicating that
Isoprenaline phosphorylated other phosphorylation
sites in addition to the classical PKA-sites. * P < 0.05
vs Quiescence group and + P < 0.05 vs Contraction
group, in a Bonferroni post hoc test
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Table 2 Overview of the endogenous phosphorylation levels from 1D- (expressed in arbitrary units) and 2D-gel electrophoresis (expressed as percentage of total protein)
Group cMyBP-C (a. u.) cTnI (a. u.) MLC-2 (a. u.) cTnT (%) MLC-1 (%) MLC-2 (%)
Q1 (0.2 mM Ca2+) 7.5 ± 1.3 31.8 ± 3.2 22.9 ± 2.6 81.3 ± 3.4 13.9 ± 1.1 23.7 ± 3.6
Q2 (1.36 mM Ca2+) 9.8 ± 0.8 32.3 ± 4.6 27.1 ± 4.2 79.6 ± 2.9 13.2 ± 0.8 21.3 ± 2.8
Quiescence 8.8 ± 0.8a 32.1 ± 2.8a 25.2 ± 2.6a, b 80.3 ± 1.8 13.5 ± 0.6a 22.4 ± 2.1a, b
C1 (1.36 mM Ca2+) 12.9 ± 2.4 39.8 ± 4.3 67 ± 15 81.4 ± 2.4 13.8 ± 1.6 35.9 ± 3.7
C2 (2.5 mM Ca2+ + OA) 12.0 ± 4.4 30.6 ± 5.7 60 ± 11 75.5 ± 0.9 19.0 ± 1.7 37.9 ± 5.2
Contraction 12.6 ± 1.8a 35.6 ± 3.0a 64 ± 10 79.1 ± 1.7 15.8 ± 1.3 36.7 ± 2.9
Iso1 30.9 ± 4.6 115 ± 18 92 ± 12 75.2 ± 2.2 17.5 ± 2.4 41.9 ± 6.9
Iso2 (+ OA) 34.1 ± 4.3 124 ± 12 84 ± 22 77.6 ± 1.5 20.5 ± 2.6 42.2 ± 7.4
Isoprenaline 32.5 ± 3.0 120 ± 10 88 ± 12 76.4 ± 1.3 19.0 ± 1.7 42.0 ± 4.7
aP < 0.05 vs Isoprenaline group; bP < 0.05 vs Contraction group
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■ Time-dependent phosphorylation by PKA
To assess the time course and magnitude of PKA-in-
duced phosphorylation of cMyBP-C and cTnI, suspen-
sions of cardiomyocytes from a sample of the Quies-
cence group, where phosphorylation was low, were
incubated with recombinant PKA as described in the
Methods.The data and the single exponential curve fit-
tings are shown in Fig.6 (panels D and E).In both cases,
the time constant amounted to approximately 10 min,
indicating that with the activity used, PKA-induced
phosphorylation saturated within 60 min. Comparison
of the final levels reached with the corresponding levels
in Fig.6A and B clearly illustrates that cMyBP-C and
cTnI phosphorylation was not complete in the Contrac-
tion group, while Isoprenaline treatment resulted in
phosphorylation levels that were higher than those at-
tained after PKA treatment.This latter finding suggests
that Isoprenaline also caused phosphorylation of other
sites on cMyBP-C and cTnI,distinct from the PKA-sites
(cTnI: Ser23/24; cMyBP-C: S279/288/308).
■ Relation between force development and contractile
protein phosphorylation
As expected from the absence of any difference in Fmax,
Fpas,and k tr between groups,no significant correlations
were observed between these parameters and the en-
dogenous levels of cMyBP-C,cTnI and MLC-2 phospho-
rylation in tissue from the different animals. On the
other hand, significant positive correlations were ob-
served between the pCa50 values from the different ani-
mals and endogenous phosphorylation levels.R2 values
ranged between 0.20 and 0.37 (P<0.02),After PKA,the
slopes of the regression lines were reduced but the rela-
tions remained significant with R2 values of 0.22 and
0.23,except for MLC-2.(R2=0.03,P>0.05).
The overall correlation between the endogenous
cTnI and cMyBP-C phosphorylation levels (Fig.7)
turned out to be positive and highly significant.The re-
lation within the Isoprenaline group was also significant
and rather similar to the overall relation. The relations
within the Quiescence and Contraction group were not
significant. There was some variability in the cMyBP-C
phosphorylation levels within the Contraction and Iso-
prenaline group. This variability, however, did not ap-
pear to be associated with the differences in the Ca2+-
concentration in the Contraction group nor with the
presence of okadaic acid in the Contraction and Isopre-
naline subgroups.
Discussion
The phosphorylation levels of the contractile proteins
varied considerably with the experimental conditions
used.Pacing the Langendorff perfused hearts at 5 Hz re-
sulted in an almost 2-fold increase in MLC-2 phospho-
rylation (relative to the Quiescence group) and,in ~50%
ofthe cases,in an increase in cMyBP-C phosphorylation,
while cTnI phosphorylation remained constant. Addi-
tion of β-agonist Isoprenaline to the electrically paced
hearts resulted in 3.7-fold increases, relative to Quies-
cence, in both cMyBP-C and cTnI phosphorylation.
These alterations in phosphorylation had a large impact
on Ca2+-sensitivity but not on maximum force and ktr.
■ Alterations in contractile protein phosphorylation
The phosphorylation status of contractile proteins is de-
termined by the kinase–phosphatase balance inside the
cardiomyocytes. In quiescent Langendorff-perfused
hearts MLC-1, MLC-2, cMyBP-C and cTnI were mainly
dephosphorylated, indicating that the relevant balance
had been shifted in favour of phosphatase activity.MLC-
1 phosphorylation increased significantly from
13.5±0.6% to 19.0±1.7% in the Isoprenaline group.
The kinase involved in MLC-1 phosphorylation is un-
known: it could be phosphorylated in vitro by MLCK,
but only in the presence of ATPγS and not in the pres-
ence of 32P-labeled γATP [27] and, in vivo, by 0.1 mM
adenosine [1]. The increase in MLC-2 phosphorylation
in the Contraction group with respect of the Quiescence
group indicates that a marked increase in intracellular
Ca2+ by pacing is required to activate the Ca2+-calmod-
ulin dependent MLCK.The averaged levels of cMyBP-C
and cTnI phosphorylation in the Contraction group
were not significantly increased. However, the variabil-
ity in cMyBP-C phosphorylation in this group suggests
Fig. 7 Relation between cTnI and cMyBP-C phosphorylation. The overall regres-
sion line (interrupted) was calculated on the basis of the individual data points in
the Quiescence (Q, white), Contraction (C, gray) and Isoprenaline (Iso, black) group
(R2 = 0.78, P < 0.0001). Regression lines are also shown for the Contraction
(R2 = 0.02, P > 0.05) and Isoprenaline group (R2 = 0.66, P < 0.02)
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AllThe ktrat saturating Ca2+-concentration and Ca2+-de-
pendence of ktrin the different experimental groups did
not differ significantly. The absence of an effect of
cMyBP-C phosphorylation on maximum ktr is in agree-
ment with the results of Stelzer etal. [36, 38]. Their re-
sults at submaximal activation indicate that ablation of
murine cardiac cMyBP-C and PKA phosphorylation of
cMyBP-C both accelerate the rate of force generation.
Our measurements at submaximal activation suggested
a small reduction in ktr after PKA treatment,i.e.a slow-
ing of force generation,in particular in the Contraction
group. It should be noted that we studied the Ca2+-de-
pendence of ktr in the pCa range between 4.5 and 5.4,
where the Ca2+-dependent reduction in ktr was quite
modest.
The Ca2+-sensitivity in the Quiescent group was
larger than in the Contraction and Isoprenaline groups
(P<0.05). The origin of this difference is not clear, but
since the effect of PKA was larger in the Quiescent group
than in the Contraction and Isoprenaline groups, we
consider it likely that it is a consequence of differences
in cAMP-dependent phosphorylation. If this would be
the case, minor differences in phosphorylation at low
cAMP levels may have a considerably larger impact on
Ca2+-sensitivity than at moderate or high levels.
The passive force decreased significantly after PKA
treatment.This observation is similar to the findings in
our Laboratory in cardiomyocytes isolated from biop-
sies from heart failure patients with diastolic dysfunc-
tion [3]. Recent studies indicate that the reduction in
passive force could be caused by the phosphorylation of
titin [10,44].
■ Effects of phosphorylation on Ca2+-sensitivity
PKA phosphorylation desensitised the myofilaments in
all groups.The magnitude of this effect depended on the
endogenous phosphorylation levels since similar pCa50
values were attained after PKA treatment.These experi-
ments indicate that the PKA-sensitive phosphorylation
sites on cMyBP-C and/or cTnI were not saturated under
basal conditions even in the Isoprenaline group. Addi-
tional evidence to support this notion originates from
the observations that the final phosphorylation levels of
cMyBP-C and cTnI in the cardiomyocyte suspension af-
ter PKA-treatment exceeded the average values in the
Quiescence and Contraction group. The effects of PKA
in the Isoprenaline group also indicate that,although the
dose used was in the high range of values reported in the
literature, Isoprenaline did not result in complete satu-
ration of the PKA sites. Since in preliminary experi-
ments pressure development stabilised within 1 min fol-
lowing Isoprenaline administration, these observations
could be caused by a lag in phosphorylation of contrac-
tile proteins relative to that of Ca2+-handling proteins
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that the activity of CaMK II may have been increased
near to the threshold for suprabasal cMyBP-C phospho-
rylation.
The correspondence between the cMyBP-C and cTnI
phosphorylation levels in the Quiescence hearts per-
fused with 0.2 mM and 1.36 mM CaCl2 was unexpected.
McClellan etal. [24] reported a large decrease in the
level of cMyBP-C phosphorylation when the Ca2+ con-
centration in the incubation solution for the cardiac tra-
beculae was reduced from 2.5 mM to 1.25 mM.This dif-
ference could be explained by a temperature-dependent
shift in the kinase–phosphatase balance (e.g.[25]) since
our experiments in Langendorff-perfused hearts were
carried out at 37 °C, and those of McClellan etal. at 23
°C.
Addition of Isoprenaline to the electrically paced (5
Hz) heart caused marked elevations of the cMyBP-C and
cTnI phosphorylation levels,but did not result in a fur-
ther significant increase in MLC-2 phosphorylation.The
increases in cMyBP-C and cTnI phosphorylation are
consistent with literature data (e.g. [5]) and can be at-
tributed to the increased activity of PKA but,because of
the associated rise in the time-averaged intracellular
Ca2+ concentration [2],altered activities of the Ca2+-de-
pendent kinases CaMK II and classical PKC isoforms
and,indirectly,ofphosphatases such as PP-1 [22] may be
involved as well.The notion that Isoprenaline phospho-
rylates other sites on cTnI and cMyBP-C is supported by
the observation that the phosphorylation levels attained
exceeded those obtained in the myocyte suspension af-
ter PKA treatment. On the other hand, the finding that
the phosphorylation level of MLC-2 was not increased
may be attributed by substrate specificity of the (Ca2+-
dependent) kinases and phosphatases involved.
■ Phosphorylation and force development
The maximum force generating capacity (Fmax) in the
different experimental groups studied was very similar.
Moreover,as was observed in previous studies (e.g.[16,
40]),Fmax was not influenced by PKA treatment.This in-
dicates that phosphorylation by PKA of cMyBP-C and
cTnI did not modulate Fmax. These observations are at
variance with the results of McClellan etal. obtained in
cardiac trabeculae where cMyBP-C phosphorylation re-
sulted in an increase of Fmax. The reason for this differ-
ence is unclear and previous data are equivocal: a large
body of evidence has accumulated from transgenic ani-
mals [18, 38] and by adding peptide fragments of
cMyBP-C [14,23] as well as extraction of cMyBP-C [15]
that cMyBP-C is able to modulate the isometric force
and kinetics of force generation in cardiac tissue at sub-
maximal levels of activation but not at saturating Ca2+-
concentrations. However, other reports indicate that
cMyBP-C is able to influence Fmax [19,20].486 Basic Research in Cardiology, Vol. ■, No. ■(200■)
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and/or a delayed onset of dose-dependent activation of
phosphatases.
Since cMyBP-C and cTnI phosphorylation are
strongly associated (Fig.6D), it is not possible from
these experiments to distinguish directly between ef-
fects of cMyBP-C and cTnI phosphorylation on Ca2+-
sensitivity of force development.A number of studies in
transgenic animals, however, indicated that cMyBP-C
phosphorylation has considerable impact on cardiac
contractility,but not directly on Ca2+-sensitivity of iso-
metric force [7,16,17].
Olsson etal.[31] have shown that an increase in MLC-
2 phosphorylation from 7 to 58% resulted in an increase
in Ca2+-sensitivity corresponding to 0.06 pCa units.Our
data provided evidence for an even stronger,inverse as-
sociation between MLC-2 phosphorylation and pCa50.
Regression analysis indicated that this association was
lost after PKA treatment.The cMyBP-C and cTnI phos-
phorylation levels in the Quiescence and Contraction
group were very similar. Therefore our results indicate
the presence of a strong interaction between the effects
of phosphorylation of cTnI and MLC-2 on Ca2+-sensi-
tivity.Since the intrinsic positive effect of MLC-2 phos-
phorylation did not become visible after PKA treatment,
this interaction might be the consequence of the coordi-
nated action of different kinases and phosphatases, re-
sulting in a specific pattern of phosphate incorporation
on the interacting proteins.
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